Search Patents
  • Patent number: 10882808
    Abstract: A method for producing hemp oil, comprising decarboxylation of CBDA in hemp oil; short-path evaporation of CBD from the decarboxylated hemp oil to produce CBD oil; selective THC to CBN conversion performed on the decarboxylated hemp oil.
    Type: Grant
    Filed: July 15, 2019
    Date of Patent: January 5, 2021
    Assignee: CV SCIENCES, INC.
    Inventors: Michael J. Mona, III, Joshua A. Hartsel, Greg Waterbury
  • Patent number: 11344593
    Abstract: A method to produce a consistent product batch of cannabis and hemp plant active ingredients by isolating and separating the cannabis and hemp plant ingredients in prior processes and recombining the isolated ingredients in specify amounts for the final product. Encapsulating active ingredients together at different body internal release times to even out the active ingredient effects on the body over a time period to reduce highs and lows.
    Type: Grant
    Filed: August 19, 2020
    Date of Patent: May 31, 2022
    Inventor: Michael Anderson
  • Publication number: 20170209390
    Abstract: The present invention relates to the use of 7-hydroxy-cannabidol (7-OH-CBD) and/or 7-hydroxy-cannabidivarin (7-OH-CBDV) in the treatment of epilepsy. Preferably the cannabinoid metabolites are isolated from plants to produce a highly purified extract or can be reproduced synthetically.
    Type: Application
    Filed: June 29, 2015
    Publication date: July 27, 2017
    Inventors: Colin Stott, Nick Jones, Benjamin Whalley, Gary Stephens, Claire Williams
  • Publication number: 20210259985
    Abstract: A method of infusing CBD oil into polyester yarns or polymer fibrous structures to establish reservoirs of CBD in said yarns or structures of sufficient integrity to withstand multiple washing cycles while periodically allowing migration of CBD from said reservoirs to the skin of a wearer of a product made from the infused yarns or polymer fibrous structures
    Type: Application
    Filed: February 16, 2021
    Publication date: August 26, 2021
    Inventor: David HALL
  • Publication number: 20210163387
    Abstract: Herein are described apparatus and processes for the preparation of cannabinoids, such as cannabidiol (CBD) and derivatives thereof. The apparatus and processes described can be used for the one-step, flow-mediated synthesis of cannabidiol and derivatives with improved overall yield, material throughput, and product purity relative to batch processes.
    Type: Application
    Filed: January 14, 2021
    Publication date: June 3, 2021
    Applicant: TRUSTEES OF BOSTON UNIVERSITY
    Inventors: John A. PORCO, JR., Aaron B. BEELER, Lauren E. BROWN, Richard V. TRILLES
  • Patent number: 10351498
    Abstract: A method for producing hemp oil, comprising decarboxylation of CBDA in hemp oil; short-path evaporation of CBD from the decarboxylated hemp oil to produce CBD oil; selective THC to CBN conversion performed on the decarboxylated hemp oil.
    Type: Grant
    Filed: April 28, 2016
    Date of Patent: July 16, 2019
    Assignee: CV SCIENCES, INC.
    Inventors: Michael J. Mona, Joshua A. Hartsel, Greg Waterbury
  • Publication number: 20220304353
    Abstract: An ingestible composition and method for providing electrolytes and for other beneficial health effects related to digestion, nutrient absorption, pain prevention and alleviation, blood pressure reduction, and anxiety relief. The composition includes minerals, mastica, vitamin C, and a cannabinoid compound. The cannabinoid compound can be cannabidiol or another cannabinoid. The composition can be produced in solid form such as a powder or in liquid form as a beverage.
    Type: Application
    Filed: March 29, 2022
    Publication date: September 29, 2022
    Applicant: Health Well CBD Corp.
    Inventor: Steven Adelstein
  • Patent number: 10981850
    Abstract: Herein are described apparatus and processes for the preparation of cannabinoids, such as cannabidiol (CBD) and derivatives thereof. The apparatus and processes described can be used for the one-step, flow-mediated synthesis of cannabidiol and derivatives with improved overall yield, material throughput, and product purity relative to batch processes.
    Type: Grant
    Filed: April 14, 2020
    Date of Patent: April 20, 2021
    Assignee: TRUSTEES OF BOSTON UNIVERSITY
    Inventors: John A. Porco, Aaron B. Beeler, Lauren E. Brown, Richard V. Trilles
  • Patent number: 11240978
    Abstract: The present invention discloses a hemp plant variety designated NBS CBD-1. The cultivar is a feminized, autoflowering, high CBD hemp variety. The plant and products thereof can be useful for a variety of medicinal uses, including movement disorders, anxiety, and pain, as well as a variety of industrial uses. Also provided are tissues cultures, seeds, and plant cells of the NBS CBD-1 variety.
    Type: Grant
    Filed: June 24, 2020
    Date of Patent: February 8, 2022
    Assignee: Phylos Bioscience, Inc.
    Inventor: Harold Frazier
  • Publication number: 20210251950
    Abstract: A method of producing a cannabinoid nanoparticle carrier composition for administration to a human and thereafter producing a consumable food product including the cannabinoid nanoparticle emulsification.
    Type: Application
    Filed: May 7, 2021
    Publication date: August 19, 2021
    Inventor: Aaron Miles
  • Publication number: 20200206152
    Abstract: The present invention relates to the use of 7-hydroxy-cannabidol (7-OH-CBD) and/or 7-hydroxy-cannabidivarin (7-OH-CBDV) in the treatment of epilepsy. Preferably the cannabinoid metabolites are isolated from plants to produce a highly purified extract or can be reproduced synthetically.
    Type: Application
    Filed: October 3, 2019
    Publication date: July 2, 2020
    Applicant: GW Research Limited
    Inventors: Colin Stott, Nick Jones, Benjamin Whalley, Gary Stephens, Claire Williams
  • Patent number: 11406914
    Abstract: Systems and methods for extracting a compound of interest from plant material, such as acannabidiol (CBD) from cannabis, are provided. Particularly, the disclosed systems and methods utilize a crude oil to separate water, fats, and proteins prior to preparation of a CBD distillate. The systems and methods are operable with conventional solvents containing between about 5 wt % and about 8 wt % water.
    Type: Grant
    Filed: July 17, 2020
    Date of Patent: August 9, 2022
    Assignee: Pacific Import Manufacturing, Inc.
    Inventor: Minyu Shi
  • Publication number: 20240082267
    Abstract: An edible having health benefits of the present disclosure consists of corn syrup, cane sugar, and less than or equal to 0.30% pure THC, CBD distillate and/or CBD isolate. An edible having health benefits of the present disclosure consists of corn syrup, can sugar, and greater than 0.3% THC, CBD distillate and/or CBD isolate.
    Type: Application
    Filed: September 8, 2022
    Publication date: March 14, 2024
    Applicant: Innovative Patent Company, LLC
    Inventors: Kishan Patel, Matthew Rizzio, Harshad Patel
  • Publication number: 20210113488
    Abstract: The method comprising melting a composition of matter comprising paraffin wax, mineral oil, aloe vera and CBD, placing a body member into said melted composition several times, withdrawing the body member from said composition, allowing the composition to solidify on the body member and peeling the solidified composition from said body member, said composition being solid, non-tacky, non-sticky and essentially non-material depositing at room temperature.
    Type: Application
    Filed: October 22, 2019
    Publication date: April 22, 2021
    Inventor: Edmund M. Dunn
  • Publication number: 20220331266
    Abstract: The application provides a composition comprising cannadibiol, a fatty acid component comprising a balanced amount of omega-3 and omega-6 fatty acids, and a sterol and optionally a vitamin E compound. The composition has been shown to be well tolerated and supportive when administered to subjects suffering from or at risk of developing a skin disorder and/or an inflammatory condition, such as atopic dermatitis. Also disclosed are methods of supporting the immune system and skin health of a subject involving administration of the compositions.
    Type: Application
    Filed: June 26, 2020
    Publication date: October 20, 2022
    Inventors: Layton MILLS, Margaret Ann CURTIS
  • Publication number: 20220168236
    Abstract: The method comprising melting a composition of matter comprising paraffin wax, mineral oil, aloe vera and CBD, placing a body member into said melted composition several times, withdrawing the body member from said composition, allowing the composition to solidify on the body member and peeling the solidified composition from said body member, said composition being solid, non-tacky, non-sticky and essentially non-material depositing at room temperature.
    Type: Application
    Filed: October 5, 2021
    Publication date: June 2, 2022
    Inventor: Edmund M. Dunn
  • Patent number: 9782360
    Abstract: The present invention relates to fluorine substituted CBD compounds, compositions thereof and uses thereof for the preparation of medicaments.
    Type: Grant
    Filed: August 19, 2016
    Date of Patent: October 10, 2017
    Assignees: UNIVERSIDADE DE SAO PAULO—USP, UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL—UFRGS, YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD
    Inventors: Raphael Mechoulam, Antonio Waldo Zuardi, Flavio Pereira Kapczinski, Jaime Eduardo Cecilio Hallak, Francisco Silveira Guimaraes, Jose Alexandre de Souza Crippa, Aviva Breuer
  • Publication number: 20230002341
    Abstract: In a method for aromatizing an alicyclic region of a cannabinoid, especially in enantiopure, scalemic and/or racemic form, in particular for aromatizing the cyclohexene group in ?9-THC-C5, ?9-THCA-C5 A, ?9-THCV-C3, ?9-THCVA-C5 A, and/or scalemic or racemic mixtures of these substances, wherein an oxidizing agent is added to the cannabinoid, sulfur is used as the oxidizing agent.
    Type: Application
    Filed: June 14, 2022
    Publication date: January 5, 2023
    Applicants: Swiss CannaPharmaceutical SA, ETH Zürich
    Inventors: Erick M. CARREIRA, Roman SAROTT, Patrick PFAFF, Remo ROTH, Sarah EICHENBERGER, Jürg STÄUBLI
  • Patent number: 11793770
    Abstract: The present invention relates to the use of 7-hydroxy-cannabidol (7-OH-CBD) and/or 7-hydroxy-cannabidivarin (7-OH-CBDV) in the treatment of epilepsy. Preferably the cannabinoid metabolites are isolated from plants to produce a highly purified extract or can be reproduced synthetically.
    Type: Grant
    Filed: September 10, 2021
    Date of Patent: October 24, 2023
    Assignee: GW Research Limited
    Inventors: Colin Stott, Nick Jones, Benjamin Whalley, Gary Stephens, Claire Williams
  • Patent number: 11147776
    Abstract: The present invention relates to the use of 7-hydroxy-cannabidol (7-OH-CBD) and/or 7-hydroxy-cannabidivarin (7-OH-CBDV) in the treatment of epilepsy. Preferably the cannabinoid metabolites are isolated from plants to produce a highly purified extract or can be reproduced synthetically.
    Type: Grant
    Filed: October 3, 2019
    Date of Patent: October 19, 2021
    Assignee: GW Research Limited
    Inventors: Colin Stott, Nick Jones, Benjamin Whalley, Gary Stephens, Claire Williams
Narrow Results

Filter by US Classification